Try it as your roleGet started

E16: Other disorders of pancreatic internal secretion

E16 is a category, not a billable code. It has 11 codes under it, 10 of them billable; a claim or a chart uses one of those.

Code set
ICD-10-CM, FY2026 (United States)
Chapter
4. Endocrine, nutritional and metabolic diseases
Section
Other disorders of glucose regulation and pancreatic internal secretion (E15-E16)
Codes under it
11 (10 billable)
Notes

What E16 covers

The tabular list carries no notes at the category level; any notes are on the codes below.

Codes

Every code under E16

CodeDescriptionBillable
E16.0Drug-induced hypoglycemia without coma
Excludes1
  • diabetes with hypoglycemia without coma (E09.649)
Use additional code
  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
  • code for hypoglycemia level, if applicable (E16.A-)
Billable
E16.1Other hypoglycemia
Includes
  • Functional hyperinsulinism
  • Functional nonhyperinsulinemic hypoglycemia
  • Hyperinsulinism NOS
  • Hyperplasia of pancreatic islet beta cells NOS
Excludes1
  • diabetes with hypoglycemia (E08.649, E10.649, E11.649, E13.649)
  • hypoglycemia in infant of diabetic mother (P70.1)
  • neonatal hypoglycemia (P70.4)
Use additional code
  • code for hypoglycemia level, if applicable (E16.A-)
Billable
E16.2Hypoglycemia, unspecified
Excludes1
  • diabetes with hypoglycemia (E08.649, E10.649, E11.649, E13.649)
Use additional code
  • code for hypoglycemia level, if applicable (E16.A-)
Billable
E16.3Increased secretion of glucagon
Includes
  • Hyperplasia of pancreatic endocrine cells with glucagon excess
Billable
E16.4Increased secretion of gastrin
Includes
  • Hypergastrinemia
  • Hyperplasia of pancreatic endocrine cells with gastrin excess
  • Zollinger-Ellison syndrome
Billable
E16.8Other specified disorders of pancreatic internal secretion
Includes
  • Increased secretion from endocrine pancreas of growth hormone-releasing hormone
  • Increased secretion from endocrine pancreas of pancreatic polypeptide
  • Increased secretion from endocrine pancreas of somatostatin
  • Increased secretion from endocrine pancreas of vasoactive-intestinal polypeptide
Billable
E16.9Disorder of pancreatic internal secretion, unspecified
Includes
  • Islet-cell hyperplasia NOS
  • Pancreatic endocrine cell hyperplasia NOS
Billable
E16.AHypoglycemia levelHeader
E16.A1Hypoglycemia level 1
Includes
  • Decreased blood glucose level 1
Billable
E16.A2Hypoglycemia level 2
Includes
  • Decreased blood glucose level 2
Billable
E16.A3Hypoglycemia level 3
Includes
  • Decreased blood glucose level 3
Billable
In MedAppz

Where these codes are used

A diagnosis is coded on the visit note in CaseNotes, a coder works through discharged stays in MRDTracker, and a US practice’s claims carry the chart’s ICD-10-CM codes in US Claims. India and most other countries report in WHO’s ICD-10 or ICD-11; MedAppz loads ICD-11 today, and WHO’s ICD-10 file is still to come.

From the ICD-10-CM FY2026 tabular list published by CDC’s National Center for Health Statistics (a US government work, free to reuse). Check the release in force before you code a claim. The source file